When you’re developing CBD food and beverage products, formulation matters. Substantiated clinical data must always guide your choices, not buzzwords or pseudoscientific guesses.
In this complimentary webinar we’ll review the just-published results from the CBD industry’s first human clinical study of pharmacokinetics in food and supplements—and address some of the nonsensical nomenclature that should not be dominating the product development decisions you are making.
Don’t miss it!
